{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00334",
      "entity_text" : "IL-23",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P01579",
      "entity_text" : "IFNgamma",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "This leads to the notion that PDE4 inhibitors may be more potent in the treatment of IL-12 / IL-23, thus IFNgamma / IL-17 dominated responses than Th2 ones.",
  "reading_complete" : "2020-08-04T13:31:14Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T13:25:03Z",
  "trigger" : "leads",
  "evidence" : [ "leads to the notion that PDE4 inhibitors may be more potent in the treatment of IL-12/IL-23, thus IFNgamma" ],
  "pmc_id" : "3680635",
  "score" : 0
}